Lin, L., Wu, X., Yan, S., Zhu, Y., Yan, Z., Lv, D., & Ge, H. (2020). Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations. Onco Targets Ther.
Citação norma ChicagoLin, Ling, Xiaomai Wu, Shuangquan Yan, Yefei Zhu, Zhengqing Yan, Dongqing Lv, and Hongfei Ge. "Response to Afatinib in a Patient With NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations." Onco Targets Ther 2020.
Deismireacht MLALin, Ling, et al. "Response to Afatinib in a Patient With NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations." Onco Targets Ther 2020.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.